Literature DB >> 2923608

Enhanced myocardial preservation by nicotinic acid, an antilipolytic compound: mechanism of action.

S Datta1, D K Das, R M Engelman, H Otani, J A Rousou, R H Breyer, J Klar.   

Abstract

The cardioprotective effects of an antilipolytic compound, nicotinic acid, on arrested-reperfused myocardium were investigated in the isolated in situ pig heart preparation. Hearts were preperfused for 15 min in the presence of (5-3H)-glucose and (U-14C)-palmitic acid. Half of the hearts were then perfused with 0.08 mM nicotinic acid for an additional 15-min period, while the remaining control hearts received unmodified perfusion. Arrest was then induced in all animals for 2 h using hypothermic K+ cardioplegia, followed by 60 min of normothermic reperfusion. In control hearts, there were significantly greater levels of long-chain acyl Co-A and acyl carnitine and lower levels of membrane phospholipids than in the nicotinic acid group. While nicotinic acid inhibited beta-oxidation during pre-ischemia and reperfusion, it also prevented the degradation of membrane phospholipids. The net result was a reduction of free fatty acid accumulation during arrest and reperfusion in the nicotinic acid group. Glycolysis, as reflected in 3H2O production, was significantly increased by nicotinic acid administration. In the control heart as compared to the nicotinic acid group, the incorporation of 14C-label from palmitate into triglyceride and cholesterol during arrest was enhanced, while incorporation into phospholipids was depressed. The cardioprotective effects of nicotinic acid were demonstrated by decreased release of creatine kinase and improved coronary blood flow, and cardiac contractility in the reperfused myocardium supplemented with nicotinic acid compared to the control group. These results suggest that nicotinic acid significantly protects the arrested-reperfused myocardium by a) preventing elevation of myocardial fatty acid levels, b) stimulating glycolysis by limiting fatty acid oxidation, c) inhibiting degradation of membrane phospholipids, and d) preventing accumulation of fatty acid metabolites with harmful detergent properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923608     DOI: 10.1007/BF01907004

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  27 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers.

Authors:  H Otani; R M Engelman; J A Rousou; R H Breyer; D K Das
Journal:  J Mol Cell Cardiol       Date:  1986-09       Impact factor: 5.000

Review 3.  Membrane-derived lipids and the pathogenesis of ischemic myocardial damage.

Authors:  A M Katz
Journal:  J Mol Cell Cardiol       Date:  1982-11       Impact factor: 5.000

4.  Fatty acid effects on membranes: possible role in the pathogenesis of ischemic myocardial damage.

Authors:  A M Katz; F C Messineo
Journal:  J Mol Cell Cardiol       Date:  1982-09       Impact factor: 5.000

5.  Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction.

Authors:  L H Opie; P Owen
Journal:  Am J Cardiol       Date:  1976-09       Impact factor: 2.778

6.  Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury.

Authors:  H Otani; R M Engelman; R H Breyer; J A Rousou; S Lemeshow; D K Das
Journal:  J Thorac Cardiovasc Surg       Date:  1986-08       Impact factor: 5.209

7.  Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers.

Authors:  H Otani; R M Engelman; J A Rousou; R H Breyer; S Lemeshow; D K Das
Journal:  J Thorac Cardiovasc Surg       Date:  1986-02       Impact factor: 5.209

8.  Distribution of coronary blood flow during acute coronary occlusion in dogs. Effect of nicotinic acid and sodium salicylate.

Authors:  H Vik-Mo
Journal:  Scand J Clin Lab Invest       Date:  1977-12       Impact factor: 1.713

9.  Fatty acid metabolism in hearts containing elevated levels of CoA.

Authors:  G D Lopaschuk; C A Hansen; J R Neely
Journal:  Am J Physiol       Date:  1986-03

10.  Separation of neutral lipids and free fatty acids by high-performance liquid chromatography using low wavelength ultraviolet detection.

Authors:  J G Hamilton; K Comai
Journal:  J Lipid Res       Date:  1984-10       Impact factor: 5.922

View more
  4 in total

Review 1.  Modulating fatty acid oxidation in heart failure.

Authors:  Vincenzo Lionetti; William C Stanley; Fabio A Recchia
Journal:  Cardiovasc Res       Date:  2011-02-02       Impact factor: 10.787

Review 2.  Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis.

Authors:  Clifford D L Folmes; Alexander S Clanachan; Gary D Lopaschuk
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

Review 3.  Oxidative substrate metabolism during postischemic reperfusion.

Authors:  R Lerch
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

4.  Lipopolysaccharide (LPS)-induced septic shock causes profound changes in myocardial energy metabolites in pigs.

Authors:  Joaquin Lado-Abeal; Noelia Martinez-Sánchez; Jose Angel Cocho; Manuel Martín-Pastor; Isabel Castro-Piedras; M Luz Couce-Pico; Asish K Saha; Miguel López
Journal:  Metabolomics       Date:  2018-09-25       Impact factor: 4.290

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.